Literature DB >> 21352097

Adhesion-dependent Skp2 transcription requires selenocysteine tRNA gene transcription-activating factor (STAF).

Ivette Hernández-Negrete1, Graciela B Sala-Newby, Andras Perl, Gary R Kunkel, Andrew C Newby, Mark Bond.   

Abstract

Cell adhesion is essential for cell cycle progression in most normal cells. Loss of adhesion dependence is a hallmark of cellular transformation. The F-box protein Skp2 (S-phase kinase-associated protein 2) controls G(1)-S-phase progression and is subject to adhesion-dependent transcriptional regulation, although the mechanisms are poorly understood. We identify two cross-species conserved binding elements for the STAF (selenocysteine tRNA gene transcription-activating factor) in the Skp2 promoter that are essential for Skp2 promoter activity. Endogenous STAF specifically binds these elements in EMSA (electrophoretic mobility-shift assay) and ChIP (chromatin immunoprecipitation) analysis. STAF is sufficient and necessary for Skp2 promoter activity since exogenous STAF activates promoter activity and expression and STAF siRNA (small interfering RNA) inhibits Skp2 promoter activity, mRNA and protein expression and cell proliferation. Furthermore, ectopic Skp2 expression completely reverses the inhibitory effects of STAF silencing on proliferation. Importantly, STAF expression and binding to the Skp2 promoter is adhesion-dependent and associated with adhesion-dependent Skp2 expression in non-transformed cells. Ectopic STAF rescues Skp2 expression in suspension cells. Taken together, these results demonstrate that STAF is essential and sufficient for Skp2 promoter activity and plays a role in the adhesion-dependent expression of Skp2 and ultimately cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21352097      PMCID: PMC3105252          DOI: 10.1042/BJ20101798

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  44 in total

1.  Interaction between ubiquitin-protein ligase SCFSKP2 and E2F-1 underlies the regulation of E2F-1 degradation.

Authors:  A Marti; C Wirbelauer; M Scheffner; W Krek
Journal:  Nat Cell Biol       Date:  1999-05       Impact factor: 28.824

Review 2.  The ubiquitin-proteasome system in cardiovascular diseases-a hypothesis extended.

Authors:  Joerg Herrmann; Aaron Ciechanover; Lilach O Lerman; Amir Lerman
Journal:  Cardiovasc Res       Date:  2004-01-01       Impact factor: 10.787

3.  p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells.

Authors:  H Sutterlüty; E Chatelain; A Marti; C Wirbelauer; M Senften; U Müller; W Krek
Journal:  Nat Cell Biol       Date:  1999-08       Impact factor: 28.824

4.  SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27.

Authors:  A C Carrano; E Eytan; A Hershko; M Pagano
Journal:  Nat Cell Biol       Date:  1999-08       Impact factor: 28.824

5.  The Small RNA gene activator protein, SphI postoctamer homology-binding factor/selenocysteine tRNA gene transcription activating factor, stimulates transcription of the human interferon regulatory factor-3 gene.

Authors:  Claire M Mach; Brian W Hargrove; Gary R Kunkel
Journal:  J Biol Chem       Date:  2001-11-27       Impact factor: 5.157

6.  Role of ZNF143 in tumor growth through transcriptional regulation of DNA replication and cell-cycle-associated genes.

Authors:  Hiroto Izumi; Tetsuro Wakasugi; Shohei Shimajiri; Akihide Tanimoto; Yasuyuki Sasaguri; Eiji Kashiwagi; Yoshihiro Yasuniwa; Masaki Akiyama; Bin Han; Ying Wu; Takeshi Uchiumi; Tokuzo Arao; Kazuto Nishio; Ryuta Yamazaki; Kimitoshi Kohno
Journal:  Cancer Sci       Date:  2010-09-23       Impact factor: 6.716

7.  Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication.

Authors:  K Nakayama; H Nagahama; Y A Minamishima; M Matsumoto; I Nakamichi; K Kitagawa; M Shirane; R Tsunematsu; T Tsukiyama; N Ishida; M Kitagawa; K Nakayama; S Hatakeyama
Journal:  EMBO J       Date:  2000-05-02       Impact factor: 11.598

8.  Transcriptional regulation of the mouse cytosolic chaperonin subunit gene Ccta/t-complex polypeptide 1 by selenocysteine tRNA gene transcription activating factor family zinc finger proteins.

Authors:  H Kubota; S Yokota; H Yanagi; T Yura
Journal:  J Biol Chem       Date:  2000-09-15       Impact factor: 5.157

9.  The F-box protein Skp2 is a ubiquitylation target of a Cul1-based core ubiquitin ligase complex: evidence for a role of Cul1 in the suppression of Skp2 expression in quiescent fibroblasts.

Authors:  C Wirbelauer; H Sutterlüty; M Blondel; M Gstaiger; M Peter; F Reymond; W Krek
Journal:  EMBO J       Date:  2000-10-16       Impact factor: 11.598

10.  Role of the F-box protein Skp2 in adhesion-dependent cell cycle progression.

Authors:  A C Carrano; M Pagano
Journal:  J Cell Biol       Date:  2001-06-25       Impact factor: 10.539

View more
  14 in total

1.  Endothelin-1 stimulates expression of cyclin D1 and S-phase kinase-associated protein 2 by activating the transcription factor STAT3 in cultured rat astrocytes.

Authors:  Yutaka Koyama; Satoshi Sumie; Yasutaka Nakano; Tomoya Nagao; Shiho Tokumaru; Shotaro Michinaga
Journal:  J Biol Chem       Date:  2019-01-22       Impact factor: 5.157

2.  Adenosine monophosphate-activated protein kinase-α2 deficiency promotes vascular smooth muscle cell migration via S-phase kinase-associated protein 2 upregulation and E-cadherin downregulation.

Authors:  Ping Song; Yanhong Zhou; Kathleen A Coughlan; Xiaoyan Dai; Hairong Xu; Benoit Viollet; Ming-Hui Zou
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-10-10       Impact factor: 8.311

3.  AMPKα2 deletion exacerbates neointima formation by upregulating Skp2 in vascular smooth muscle cells.

Authors:  Ping Song; Shuangxi Wang; Chaoyong He; Shaobin Wang; Bin Liang; Benoit Viollet; Ming-Hui Zou
Journal:  Circ Res       Date:  2011-10-06       Impact factor: 17.367

4.  The transcriptional activator ZNF143 is essential for normal development in zebrafish.

Authors:  Kari M Halbig; Arne C Lekven; Gary R Kunkel
Journal:  BMC Mol Biol       Date:  2012-01-23       Impact factor: 2.946

5.  cAMP-induced actin cytoskeleton remodelling inhibits MKL1-dependent expression of the chemotactic and pro-proliferative factor, CCN1.

Authors:  Aparna Duggirala; Tomomi E Kimura; Graciela B Sala-Newby; Jason L Johnson; Yih-Jer Wu; Andrew C Newby; Mark Bond
Journal:  J Mol Cell Cardiol       Date:  2014-11-18       Impact factor: 5.000

6.  ZNF143 provides sequence specificity to secure chromatin interactions at gene promoters.

Authors:  Swneke D Bailey; Xiaoyang Zhang; Kinjal Desai; Malika Aid; Olivia Corradin; Richard Cowper-Sal Lari; Batool Akhtar-Zaidi; Peter C Scacheri; Benjamin Haibe-Kains; Mathieu Lupien
Journal:  Nat Commun       Date:  2015-02-03       Impact factor: 14.919

7.  The Hippo pathway mediates inhibition of vascular smooth muscle cell proliferation by cAMP.

Authors:  Tomomi E Kimura; Aparna Duggirala; Madeleine C Smith; Stephen White; Graciela B Sala-Newby; Andrew C Newby; Mark Bond
Journal:  J Mol Cell Cardiol       Date:  2015-11-25       Impact factor: 5.000

8.  Modulation of gene expression via overlapping binding sites exerted by ZNF143, Notch1 and THAP11.

Authors:  Richard Patryk Ngondo-Mbongo; Evelyne Myslinski; Jon C Aster; Philippe Carbon
Journal:  Nucleic Acids Res       Date:  2013-02-13       Impact factor: 16.971

9.  The combination of strong expression of ZNF143 and high MIB-1 labelling index independently predicts shorter disease-specific survival in lung adenocarcinoma.

Authors:  Y Kawatsu; S Kitada; H Uramoto; L Zhi; T Takeda; T Kimura; S Horie; F Tanaka; Y Sasaguri; H Izumi; K Kohno; S Yamada
Journal:  Br J Cancer       Date:  2014-04-15       Impact factor: 7.640

10.  Inhibition of Egr1 expression underlies the anti-mitogenic effects of cAMP in vascular smooth muscle cells.

Authors:  Tomomi E Kimura; Aparna Duggirala; Charles C T Hindmarch; Richard C Hewer; Mei-Zhen Cui; Andrew C Newby; Mark Bond
Journal:  J Mol Cell Cardiol       Date:  2014-02-15       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.